Chiron Capital Management LLC Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Chiron Capital Management LLC trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 17.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 13,280 shares of the biopharmaceutical company’s stock after selling 2,898 shares during the quarter. Gilead Sciences comprises about 0.9% […]

Related Keywords

United States ,Merdad Parsey ,Complera Eviplera ,Fortitude Family Office ,Barclays ,Tompkins Financial Corp ,Gilead Sciences Company Profile ,Gilead Sciences ,Gilead Sciences Inc ,Cantor Fitzgerald ,News Ratings For Gilead Sciences Daily ,Quarter For Gilead Sciences ,Wealth Management Group ,Rakuten Securities Inc ,Nasdaq ,Gilead Sciences Trading ,Securities Exchange Commission ,Chiron Capital Management ,Gilead Sciences Announces Dividend ,Free Report ,Capital Management ,Financial Corp ,Family Office ,Rakuten Securities ,Get Free Report ,Exchange Commission ,Gilead Sciences Daily ,